Pharmaceutical group · Germany
Grünenthal
A group of 12 companies with 261 medicines in 8 countries.
Group structure
12 companies in 6 countries
Loading your page…
Pharmaceutical group · Germany
A group of 12 companies with 261 medicines in 8 countries.
12 companies in 6 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 261
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABSTRALCompressa sublinguale | Fentanyl | Italy | Authorised | |
| Abstral 100 microgram, tabletten voor sublinguaal gebruikTablet voor sublinguaal gebruik | Fentanyl | Netherlands | Authorised | 2011 |
| ABSTRAL 100 microgramos COMPRIMIDOS SUBLINGUALES0,1571 mg · Comprimido sublingual | Fentanyl | Spain | Marketed | 2009 |
| Abstral 200 microgram, tabletten voor sublinguaal gebruikTablet voor sublinguaal gebruik | Fentanyl | Netherlands | Authorised | 2011 |
| ABSTRAL 200 microgramos COMPRIMIDOS SUBLINGUALES0,3142 mg · Comprimido sublingual | Fentanyl | Spain | Marketed | 2009 |
| Abstral 300 microgram, tabletten voor sublinguaal gebruikTablet voor sublinguaal gebruik | Fentanyl | Netherlands | Authorised | 2011 |
| ABSTRAL 300 microgramos COMPRIMIDOS SUBLINGUALES0,47113 mg · Comprimido sublingual | Fentanyl | Spain | Marketed | 2009 |
| Abstral 400 microgram, tabletten voor sublinguaal gebruikTablet voor sublinguaal gebruik | Fentanyl | Netherlands | Authorised | 2011 |
| ABSTRAL 400 microgramos COMPRIMIDOS SUBLINGUALES0,6284 mg · Comprimido sublingual | Fentanyl | Spain | Marketed | 2009 |
| Abstral 600 microgram, tabletten voor sublinguaal gebruikTablet voor sublinguaal gebruik | Fentanyl | Netherlands | Authorised | 2011 |
| ABSTRAL 600 microgramos COMPRIMIDOS SUBLINGUALES0,9426 mg · Comprimido sublingual | Fentanyl | Spain | Marketed | 2009 |
| Abstral 800 microgram, tabletten voor sublinguaal gebruikTablet voor sublinguaal gebruik | Fentanyl | Netherlands | Authorised | 2011 |
| ABSTRAL 800 microgramos COMPRIMIDOS SUBLINGUALES1,257 mg · Comprimido sublingual | Fentanyl | Spain | Marketed | 2009 |
| ACTILOGIC 700 MG APOSITO ADHESIVO MEDICAMENTOSO700 mg · Apósito adhesivo medicamentoso | Lidocaine | Spain | Marketed | 2018 |
| ADOLONTA 100 mg/2 ml SOLUCION INYECTABLE Y PARA PERFUSION100 mg · Solución inyectable y para perfusión | Tramadol | Spain | Marketed | 1992 |
| ADOLONTA 100 mg/ ml SOLUCION ORAL100 mg · Solución oral | Tramadol | Spain | Marketed | 1998 |
| ADOLONTA 50 mg CAPSULAS DURAS50 mg · Cápsula dura | Tramadol | Spain | Marketed | 1992 |
| ADOLONTA RETARD 100 mg COMPRIMIDOS DE LIBERACION PROLONGADA100 mg · Comprimido de liberación prolongada | Tramadol | Spain | Marketed | 1998 |
| ADOLONTA RETARD 150 mg COMPRIMIDOS DE LIBERACION PROLONGADA150 mg · Comprimido de liberación prolongada | Tramadol | Spain | Marketed | 1998 |
| ADOLONTA RETARD 200 mg COMPRIMIDOS DE LIBERACION PROLONGADA200 mg · Comprimido de liberación prolongada | Tramadol | Spain | Marketed | 1998 |
| ADOLONTA RETARD 50 mg COMPRIMIDOS DE LIBERACION PROLONGADA50 mg · Comprimido de liberación prolongada | Tramadol | Spain | Marketed | 2007 |
| ADORLAN | Tramadol, Diclofenac | Brazil | Authorised | 2020 |
| AXAGONCompressa gastroresistente | Esomeprazole | Italy | Authorised | |
| AXIAGO 20 MG COMPRIMIDOS GASTRORRESISTENTES22,3 mg · Comprimido gastrorresistente | Esomeprazole | Spain | Authorised | 2026 |
| AXIAGO 20 mg COMPRIMIDOS GASTRORRESISTENTES20 mg · Comprimido gastrorresistente | Esomeprazole | Spain | Marketed | 2001 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 123 | 116 | 7 | CompaniesAll medicines |
| Netherlands | 53 | 53 | 0 | CompaniesAll medicines |
| Italy | 27 | 27 | 0 | CompaniesAll medicines |
| Brazil | 21 | 16 | 5 | CompaniesAll medicines |
| Croatia | 17 | 17 | 0 | CompaniesAll medicines |
| Saudi Arabia | 14 | 14 | 0 | CompaniesAll medicines |
| European Union (EMA) | 5 | 3 | 2 | CompaniesAll medicines |
| Romania | 1 | 0 | 1 | CompaniesAll medicines |
Also in the registers of France, Serbia, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.